| 25/343 |
Guidelines for MRI Referral |
| 25/342 |
Missed or Delayed Hip Fracture Diagnoses |
| 25/341 |
Maternity Pain Relief and Ethnicity Data |
| 25/340 |
Tier 3 Weight Management Services |
| 25/339 |
Biologics (Dermatology) |
| 25/338 |
Mask Fit Testing |
| 25/337 |
Complaints regarding Pregnant, Transgender Patients |
| 25/336 |
Very Senior Manager (SM) |
| 25/334 |
Allegations of Antisemitism, Islamophobia and Racism against Palestinians and/or Arabs |
| 25/333 |
Trust Decontamination Services |
| 25/332 |
Agency Hires |
| 25/331 |
Generalised Myasthenia Gravis |
| 25/328 |
Framework Agencies |
| 25/326 |
Data Protection Services |
| 25/324 |
Mechanical Ventilation for MRI Patients & In-Hospital Transport |
| 25/323 |
Elastomeric Infusion Devices |
| 25/322 |
Agency Usage & Costs for AHP & HSS Staff |
| 25/321 |
Compliance with the Homelessness Reduction Act 2017 |
| 25/320 |
Direct Engagement Model & Technology Platform |
| 25/319 |
-Cide Use |
